PROFOUND MEDICAL CORP. Increase (Decrease) in Deferred Revenue
PROFOUND MEDICAL CORP. (PROF) reported Increase (Decrease) in Deferred Revenue of $164.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-06
- PROFOUND MEDICAL CORP. increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was $76.00K, a 16.92% increase year-over-year.
- PROFOUND MEDICAL CORP. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was $88.00K, a 65.08% decline year-over-year.
- PROFOUND MEDICAL CORP. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was $270.00K.
- PROFOUND MEDICAL CORP. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was -$216.00K, a 540.82% decline year-over-year.
- PROFOUND MEDICAL CORP. increase (decrease) in deferred revenue for fiscal 2025 was $371.00K.
- PROFOUND MEDICAL CORP. increase (decrease) in deferred revenue for fiscal 2024 was -$948.00K, a 606.95% decline from fiscal 2023.
- PROFOUND MEDICAL CORP. increase (decrease) in deferred revenue for fiscal 2023 was $187.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $164.00K 10-Q · filed 2026-08-06 | $434.00K derived: sum of 3 quarters · filed 2026-08-06 | $218.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $88.00K 10-Q · filed 2026-05-07 | $358.00K derived: sum of 2 quarters · filed 2026-05-07 | $142.00K derived: sum of 3 quarters · filed 2026-05-07 | $207.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $54.00K derived: sum of 2 quarters · filed 2026-03-05 | $119.00K derived: sum of 3 quarters · filed 2026-08-06 | $371.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$216.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$151.00K derived: sum of 2 quarters · filed 2026-08-06 | $101.00K 10-Q · filed 2025-11-13 | -$914.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $317.00K 10-Q · filed 2026-08-06 | -$698.00K derived: sum of 3 quarters · filed 2026-08-06 | -$649.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $252.00K 10-Q · filed 2026-05-07 | -$763.00K derived: sum of 2 quarters · filed 2026-05-07 | -$714.00K derived: sum of 3 quarters · filed 2026-05-07 | -$589.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$966.00K derived: sum of 2 quarters · filed 2026-03-05 | -$841.00K derived: sum of 3 quarters · filed 2026-03-05 | -$948.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $174.00K derived: sum of 2 quarters · filed 2025-11-13 | $67.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $18.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$107.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $187.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |